Partnering Opportunities

Superna is currently seeking to in-license candidate products for the hematology and oncology market in Canada. Our first product is Caphosol which is used to prevent and treat oral mucositis in patients who are undergoing cancer therapy.

With full regulatory and distribution capabilities, and a emerging commercial team, Superna could be the perfect option for launching your product in the Canadian cancer-care market.